150 related articles for article (PubMed ID: 22343836)
1. Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.
Derosa CA; Furusato B; Shaheduzzaman S; Srikantan V; Wang Z; Chen Y; Seifert M; Ravindranath L; Young D; Nau M; Dobi A; Werner T; McLeod DG; Vahey MT; Sesterhenn IA; Srivastava S; Petrovics G
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):150-6. PubMed ID: 22343836
[TBL] [Abstract][Full Text] [Related]
2. Osteonectin (SPARC) prognostic value in prostate cancer.
Chekhun V; Borikun T; Zadvornyi T; Mushii O; Stakhovsky E; Vitruk Y; Lukianova N
Pathol Res Pract; 2024 Feb; 254():155053. PubMed ID: 38199134
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of osteonectin/SPARC during human prostate cancer progression.
Thomas R; True LD; Bassuk JA; Lange PH; Vessella RL
Clin Cancer Res; 2000 Mar; 6(3):1140-9. PubMed ID: 10741745
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Secreted Protein, Acidic and Rich in Cysteine in Prostate Carcinogenesis: Development of a 3D Nanostructured Bone-Like Model.
Ribeiro N; Costa-Pinheiro P; Henrique R; Gomez-Lazaro M; Pereira MP; Mansur AAP; Mansur HS; Jerónimo C; Sousa SR; Monteiro FJ
J Biomed Nanotechnol; 2016 Aug; 12(8):1667-78. PubMed ID: 29342345
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy.
Moul JW
Eur Urol; 1999; 35(5-6):399-407. PubMed ID: 10325496
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor SOX-5 enhances nasopharyngeal carcinoma progression by down-regulating SPARC gene expression.
Huang DY; Lin YT; Jan PS; Hwang YC; Liang ST; Peng Y; Huang CY; Wu HC; Lin CT
J Pathol; 2008 Mar; 214(4):445-55. PubMed ID: 18085523
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
[TBL] [Abstract][Full Text] [Related]
8. SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.
Mateo F; Meca-Cortés O; Celià-Terrassa T; Fernández Y; Abasolo I; Sánchez-Cid L; Bermudo R; Sagasta A; Rodríguez-Carunchio L; Pons M; Cánovas V; Marín-Aguilera M; Mengual L; Alcaraz A; Schwartz S; Mellado B; Aguilera KY; Brekken R; Fernández PL; Paciucci R; Thomson TM
Mol Cancer; 2014 Oct; 13():237. PubMed ID: 25331979
[TBL] [Abstract][Full Text] [Related]
9. Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.
Walker SM; Knight LA; McCavigan AM; Logan GE; Berge V; Sherif A; Pandha H; Warren AY; Davidson C; Uprichard A; Blayney JK; Price B; Jellema GL; Steele CJ; Svindland A; McDade SS; Eden CG; Foster C; Mills IG; Neal DE; Mason MD; Kay EW; Waugh DJ; Harkin DP; Watson RW; Clarke NW; Kennedy RD
Eur Urol; 2017 Oct; 72(4):509-518. PubMed ID: 28408174
[TBL] [Abstract][Full Text] [Related]
10. Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma.
Dalla-Torre CA; Yoshimoto M; Lee CH; Joshua AM; de Toledo SR; Petrilli AS; Andrade JA; Chilton-MacNeill S; Zielenska M; Squire JA
BMC Cancer; 2006 Oct; 6():237. PubMed ID: 17022822
[TBL] [Abstract][Full Text] [Related]
11. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract][Full Text] [Related]
12. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
14. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
McCabe NP; Kerr BA; Madajka M; Vasanji A; Byzova TV
Neoplasia; 2011 Jan; 13(1):31-9. PubMed ID: 21245938
[TBL] [Abstract][Full Text] [Related]
15. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM
Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959
[TBL] [Abstract][Full Text] [Related]
16. Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer.
Rubicz R; Zhao S; Wright JL; Coleman I; Grasso C; Geybels MS; Leonardson A; Kolb S; April C; Bibikova M; Troyer D; Lance R; Lin DW; Ostrander EA; Nelson PS; Fan JB; Feng Z; Stanford JL
Mol Oncol; 2017 Feb; 11(2):140-150. PubMed ID: 28145099
[TBL] [Abstract][Full Text] [Related]
17. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
Leapman MS; Nguyen HG; Cowan JE; Xue L; Stohr B; Simko J; Cooperberg MR; Carroll PR
Eur Urol; 2018 Nov; 74(5):668-675. PubMed ID: 30181067
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.
Wang CS; Lin KH; Chen SL; Chan YF; Hsueh S
Br J Cancer; 2004 Nov; 91(11):1924-30. PubMed ID: 15558074
[TBL] [Abstract][Full Text] [Related]
19. The role of metastasis-associated protein 1 in prostate cancer progression.
Hofer MD; Kuefer R; Varambally S; Li H; Ma J; Shapiro GI; Gschwend JE; Hautmann RE; Sanda MG; Giehl K; Menke A; Chinnaiyan AM; Rubin MA
Cancer Res; 2004 Feb; 64(3):825-9. PubMed ID: 14871807
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
Li T; Huang S; Dong M; Gui Y; Wu D
Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
